Patrick Lin - Chief Business - Strategy Off at Processa Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business - Strategy Off
Issuer Symbol
PCSA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Patrick Lin since 10 Mar 2025

Holdings reported by Patrick Lin for Processa Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 68,000 $42,603 $1.71 01 Oct 2025 Direct Common Stock
Common Stock 1,753 $210 $0.1200 01 Jan 2026 Direct
Common Stock 1,740 $208 $0.1200 01 Jan 2026 Lin Family Trust Feb 4, 2024
Stock Options (Right to Buy) 204,000 01 Oct 2025 Direct Common Stock
Warrants 21,750 29 Jan 2025 Lin Family Trust Feb 4, 2024 Common Stock

Transactions reported by Patrick Lin for Processa Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.